Vixen Biosystems SRL
2.8 FTEVixen Biosystems reported total assets of €1.19m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026), with 2.8 full-time equivalents.
The score of Vixen Biosystems shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +181 % Total assets +1745 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vixen Biosystems's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −96,013 € | ||||
| Equity | 154,851 € | ||||
| Cash | 506,230 € | ||||
| EBITDA | −43,921 € | ||||
| Total assets | €1.19m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Vixen Biosystems's financial analysis
- Solvency13.0%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vixen Biosystems
Vixen Biosystems's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0421.258.924
- VAT number
- BE0421258924
- Peppol
- Registered · 0208:0421258924 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jan 1981
- Registered office
- 9052 Ghent
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Vixen Biosystems (SRL) has been based in Ghent since 1981, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 96,013 € and equity of 154,851 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.0%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vixen Biosystems
Companies in the same business, of comparable size and area, outside its group.
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Certor Research and experimental development on natural sciences and engineering Mechelen · balance sheet 505,224 €
- Skandi Network Business and other management consultancy activities Machelen (Brab.) · balance sheet 547,869 €
- Zomagen Biosciences Belgium Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.83m
- Innovation In Research & Engineering Solutions Research and experimental development on natural sciences and engineering Brussels · balance sheet €2.31m
- Dokter Frankie Nobels Research and experimental development on natural sciences and engineering Dendermonde · balance sheet €1.87m
- Drs Pipeleers & Marichal Research and experimental development on natural sciences and engineering Roosdaal · balance sheet €2.05m
Frequently asked questions about Vixen Biosystems
What is the revenue of Vixen Biosystems?
Vixen Biosystems files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vixen Biosystems?
In Belgium, the VAT number is the company number prefixed with BE: BE0421258924 for Vixen Biosystems, if the company is VAT-registered. Its company number (CBE) is 0421.258.924.
Where is the registered office of Vixen Biosystems?
According to the CBE register, the registered office of Vixen Biosystems is in 9052 Ghent.
What is the equity of Vixen Biosystems?
At the close of the 2025 financial year, the equity of Vixen Biosystems amounts to 154,851 €, a solvency of 13.0% of total assets.
How many people work at Vixen Biosystems?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vixen Biosystems?
The register lists 4 active mandates at Vixen Biosystems. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vixen Biosystems
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →